The purpose of this resolution is to express support for designating the week of May 3, 2026, to May 9, 2026, as "Tardive Dyskinesia Awareness Week." The goal is to raise awareness about tardive dyskinesia (TD), a movement disorder that can occur in people taking certain medications for mental health and gastrointestinal conditions. Key provisions of the resolution include a call for increased awareness of TD, which affects many individuals who are treated with dopamine receptor blocking agents, such as antipsychotics and antiemetics.